1. Home
  2. HZO vs BCYC Comparison

HZO vs BCYC Comparison

Compare HZO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$28.76

Market Cap

550.9M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$6.51

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
BCYC
Founded
1998
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
550.9M
476.6M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
HZO
BCYC
Price
$28.76
$6.51
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$34.00
$18.73
AVG Volume (30 Days)
275.2K
247.3K
Earning Date
01-30-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
$28,339,000.00
Revenue This Year
$2.11
N/A
Revenue Next Year
$4.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$6.03
52 Week High
$33.28
$14.95

Technical Indicators

Market Signals
Indicator
HZO
BCYC
Relative Strength Index (RSI) 72.70 43.09
Support Level $27.25 $6.37
Resistance Level $29.28 $6.88
Average True Range (ATR) 1.16 0.32
MACD 0.35 -0.02
Stochastic Oscillator 90.80 23.63

Price Performance

Historical Comparison
HZO
BCYC

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: